The AstraZeneca PLC ADR AZN,
fell 1.41% to $ 50.19 Thursday, on what turned out to be an all-round great trading session for the stock market, with the NASDAQ Composite Index COMP,
an increase of 2.56% to 13,067.48 and the Dow Jones Industrial Average DJIA,
increases by 0.69% to 31,041.13. The fall of the ADR broke a three-day winning streak. AstraZeneca PLC ADR closed down $ 14.75 from its 52-week high of $ 64.94, which the company hit on July 20.
The ADR underperformed on Thursday compared to some of its competitors as AbbVie Inc. ABBV,
rose 1.07% to $ 106.71, Amgen Inc. AMGN,
Up 0.33% to $ 234.02, and Gilead Sciences Inc. GILD,
increased 0.92% to $ 62.52. The trade volume (13.6 million) eclipsed the 50-day average volume of 10.2 million.
Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.